Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-19

FDA Approved: DOFETILIDE — Original Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA has approved Accord Healthcare's original application for the generic antiarrhythmic dofetilide to treat atrial fibrillation and atrial flutter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dofetilide (dofetilide)

Snippet

ORIG AP for DOFETILIDE (DOFETILIDE)